Related Experiment Video
Updated: May 1, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression
Abstract:
Pancreatic ductal adenocarcinoma (PDAC) is strikingly resistant to conventional therapeutic approaches. We previously demonstrated that the histone deacetylase-associated protein SIN3B is essential for oncogene-induced senescence in cultured cells. Here, using a mouse model of pancreatic cancer, we have demonstrated that SIN3B is required for activated KRAS-induced senescence in vivo. Surprisingly, impaired senescence as the result of genetic inactivation of Sin3B was associated with delayed PDAC progression and correlated with an impaired inflammatory response. In murine and human pancreatic cells and tissues, levels of SIN3B correlated with KRAS-induced production of IL-1α. Furthermore, evaluation of human pancreatic tissue and cancer cells revealed that Sin3B was decreased in control and PDAC samples, compared with samples from patients with pancreatic inflammation. These results indicate that senescence-associated inflammation positively correlates with PDAC progression and suggest that SIN3B has potential as a therapeutic target for inhibiting inflammation-driven tumorigenesis.
Insights
Scientists found that SIN3B protein is crucial for senescence in pancreatic cancer. Impairing SIN3B delayed tumor progression and reduced inflammation, suggesting SIN3B as a therapeutic target for pancreatic ductal adenocarcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Pancreatic ductal adenocarcinoma (PDAC) exhibits significant resistance to standard therapies.
- The histone deacetylase-associated protein SIN3B was previously identified as essential for oncogene-induced senescence in cell cultures.
Purpose of the Study:
- To investigate the role of SIN3B in activated KRAS-induced senescence in a mouse model of pancreatic cancer.
- To explore the relationship between SIN3B, senescence, inflammation, and PDAC progression.
- To evaluate SIN3B as a potential therapeutic target for inflammation-driven PDAC.
Main Methods:
- Utilized a mouse model of pancreatic cancer to study SIN3B's function in vivo.
- Genetically inactivated Sin3B to assess its impact on senescence and tumor progression.
- Analyzed SIN3B levels and their correlation with KRAS-induced IL-1α production in murine and human pancreatic cells and tissues.
- Compared SIN3B expression in control, PDAC, and pancreatic inflammation samples from human patients.
Main Results:
- SIN3B was found to be required for activated KRAS-induced senescence in vivo.
- Genetic inactivation of Sin3B led to delayed PDAC progression and an impaired inflammatory response.
- SIN3B levels correlated with KRAS-induced IL-1α production in pancreatic cells and tissues.
- SIN3B expression was decreased in PDAC samples compared to samples from patients with pancreatic inflammation.
Conclusions:
- Senescence-associated inflammation positively correlates with PDAC progression.
- SIN3B plays a critical role in regulating senescence and inflammation in pancreatic cancer.
- SIN3B represents a potential therapeutic target for inhibiting inflammation-driven pancreatic tumorigenesis.
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Canonical Wnt Signaling Pathway
Chronic Pancreatitis II: Pathophysiology
Inflammatory Bowel Disease III: Crohn's Disease
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Chronic Pancreatitis I: Introduction

